PISCATAWAY, NJ: Clinical Study Demonstrates Tolerability and Anti-Tumor Activity of Survivin mRNA Antagonist in Combination With Docetaxel in Solid Tumors; Novel mRNA Antagonists Inhibit Tumor Growth, Oncogenic Prote ...
Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.